MedTrace Logo

Evaluation and Treatment of Substance Abuse in Veterans With PTSD Disability Claims

NCT01597856 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 346

Last updated 2020-01-27

Study results available
· View outcomes & findings →

Summary

Veterans can apply for compensation and pension (C \& P) benefits for a disability related to military service. The application exam for these benefits provides an opportunity for Veterans returning from service to access VA care. The investigators will recruit Veterans applying for C \& P to participate in this study. All enrolled participants will complete questionnaires around the time of their C \& P exam related to substance abuse, PTSD, service use, and attitudes. The investigators will monitor enrolled Veterans' attendance at treatment over time, and examine whether C \& P award, substance use, and beliefs about benefits are related to treatment attendance. Some enrolled participants will be assigned to one of two study groups: a treatment group and a no-additional-treatment group. People assigned to these groups will complete the same substance abuse, PTSD, service use, and attitudes questionnaires two additional times during the study. Participants assigned to the treatment group will receive information about the relationship between substance use and PTSD and will be referred to relevant treatment. The investigators will test whether Veterans who receive no-additional-treatment have different symptoms over time and attend less treatment sessions (mental health or substance abuse) than people assigned to treatment.

Conditions

  • Attendance at Treatment
  • PTSD, Substance Use, and Attendance at Treatment

Interventions

BEHAVIORAL

SBIRT

SBIRT Therapy overview- 1. Therapist explains purpose of the therapy. 2. Inquiry about Compensation examination-ask if Veteran has questions about determination process and address concerns. 3. Discuss relationship between PTSD and substance use- long-term substance use is a form of avoidance and barrier to recovery. 4. Discuss treatment needs, administer screening, provide feedback.

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Marc I. Rosen, MD · VA Connecticut Healthcare System West Haven Campus, West Haven, CT

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-18
Primary Completion
2017-09-30
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01597856 on ClinicalTrials.gov